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Background: Smoking, poor diet, and physical inactivity account for as much as 60% of cancer risk. Latinos
experience profound disparities in health behaviors, as well as the cancers associated with them. Currently, there is
a dearth of controlled trials addressing these health behaviors among Latinos. Further, to the best of our
knowledge, no studies address all three behaviors simultaneously, are culturally sensitive, and are guided by
formative work with the target population. Latinos represent 14% of the U.S. population and are the fastest
growing minority group in the country. Efforts to intervene on these important lifestyle factors among Latinos may
accelerate the elimination of cancer-related health disparities.
Methods/design: The proposed study will evaluate the efficacy of an evidence-based and theoretically-driven
Motivation And Problem Solving (MAPS) intervention, adapted and culturally-tailored for reducing cancer risk
related to smoking, poor diet, and physical inactivity among high-risk Mexican-origin smokers who are overweight/
obese (n = 400). Participants will be randomly assigned to one of two groups: Health Education (HE) or MAPS
(HE + up to 18 MAPS counseling calls over 18 months). Primary outcomes are smoking status, servings of fruits and
vegetables, and both self-reported and objectively measured physical activity. Outcome assessments will occur at
baseline, 6 months, 12 months, and 18 months.
Discussion: The current study will contribute to a very limited evidence base on multiple risk factor intervention
studies on Mexican-origin individuals and has the potential to inform both future research and practice related to
reducing cancer risk disparities. An effective program targeting multiple cancer risk behaviors modeled after chronic
care programs has the potential to make a large public health impact because of the dearth of evidence-based
interventions for Latinos and the extended period of support that is provided in such a program.
Trial registration: National Institutes of Health Clinical Trials Registry # NCT01504919
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Over 60% of U.S. cancer mortality is attributable to to-
bacco use, poor nutrition, and physical inactivity [1,2],
with almost one-third of all cancers directly attributable to
tobacco use alone. Smoking cessation is associated with
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reproduction in any medium, provided the orstroke, and chronic lung disease [3]. Diet accounts for
35% of cancer deaths, with diets low in fat, and high in
fruits, vegetables, fiber, and grain associated with reduced
risk [4-6]. A healthy diet is protective against lung, colon
and rectum, breast, oral cavity, esophagus, stomach, pan-
creas, uterine cervix, and ovary cancer [7]. On the other
side of the energy balance equation, regular physical activ-
ity can reduce the risk of colon and breast cancer [8-10].
Additionally, balancing "energy in/energy out" (i.e., calo-
ries eaten vs. expended) is imperative to avoid weight gain
and the increased risk of cancer and other chronicLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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body weight has been found to be related to increased
risk of as many as 14 types of cancer [11]. Furthermore,
these cancer risk factors tend to be clustered, with
smokers particularly likely to be physically inactive and
have poor diets [12-14]. The presence of multiple cancer
risk factors has synergistic adverse effects on health [15].
Thus, strategies for addressing cancer risk reduction
among high-risk individuals need to address these mul-
tiple health risk behaviors.
The need for effective, culturally tailored behavior
change interventions targeted at Latinos is critically im-
portant to public health for several reasons. First, Lati-
nos, particularly of Mexican origin, are the fastest
growing and largest minority group in the U.S. There
are more than 40 million Latinos residing in the US,
representing 14% of the total population [16], and people
of Mexican origin account for 59% of this population
[16]. Second, three of the four leading causes of death
among Latinos cancer, heart disease, and stroke; [17]
share smoking, poor diet, and physical inactivity as risk
factors. Third, there are notable disparities in these risk
factors for the Latino population. For example, although
the prevalence of smoking is lower among Latinos than
among the general population 16% versus 21%; [18], La-
tinos who smoke are less likely to receive advice to quit
from a health professional, and to use cessation counsel-
ing services or medication compared to African Ameri-
can or White smokers [19]. National data indicate that
75% of Latinos do not eat the recommended servings of
fruits and vegetables and 58% are physically inactive,
with both Latino men and women being less likely to
meet the recommended levels of fruits and vegetables
and physical activity compared to non-Hispanic Whites
[20]. Fourth, there is a strong clustering of these risk
factors among Latinos and disparities exist in this clus-
tering relative to other racial/ethnic groups. Latino
smokers have both the highest prevalence of overweight/
obesity (79%) and the highest number of additional
risk factors compared to African American or White
smokers [21]. Finally, 43% of Latinos speak Spanish at
home and have limited English proficiency, whereas an-
other 36% speak predominantly Spanish at home [16].
Thus, cancer prevention efforts among Latinos should
include Spanish language programs if they hope to have
a large public health impact.
Despite the critical importance of reducing cancer
risk factors in Latinos, few stringent tests of targeted in-
terventions have been conducted examining behavior
change related to smoking cessation, diet or physical ac-
tivity. For example, in contrast to the hundreds of smok-
ing cessation treatment studies conducted among the
general population [22], a recent review found only 12
studies that targeted Latino smokers [23]. Further,although all attended to cultural or linguistic tailoring to
some extent, only five of those 12 studies utilized experi-
mental designs. None of these studies attempted to sim-
ultaneously affect smoking and another health behavior.
The situation is similar for diet and physical activity in-
terventions among Latinos. A recent review found 16
culturally tailored interventions that examined behav-
ioral outcomes (vs. knowledge/attitudes) and were tested
with an experimental design [24]. Five of the 16 exam-
ined only diet, two examined only physical activity, and
eight examined both. One study examined smoking and
fruit/vegetable consumption. Five of the 12 smoking in-
terventions and 12 of the 16 diet and physical activity in-
terventions demonstrated significant effects. Thus,
although notable efforts to create tailored or targeted in-
terventions for Latinos have been made, there continues
to be a dearth of evidence-based interventions for inter-
ventions targeting multiple cancer risk behaviors. Inter-
ventions addressing multiple cancer risk factors have
shown great promise, and there is evidence that at-
tempts to change one risk factor often leads to interest
in modifying other risk factors, reflecting potential syn-
ergies in changing overall cancer risk profiles [25-28]. In
sum, there is a compelling public health need to develop
behavior change interventions for Latinos that address
multiple cancer risk factors. Further, the development
and evaluation of behavior change interventions for Lati-
nos and other underserved groups has been identified as
a national health priority [22,29].
Study objective and aims
The goal of this randomized controlled trial is to evaluate
the efficacy of a telephone-based counseling intervention
that simultaneously addresses three cancer risk factors
(smoking, fruit/vegetable consumption, physical activity)
among overweight/obese Mexican-origin smokers in
Houston, Texas. The intervention builds on previous work
demonstrating the efficacy of the intervention for smoking
cessation among Latinos of low socioeconomic status SES;
[30], and among female smokers [31], and efficacy in
preventing postpartum smoking relapse among a diverse
sample of low SES women [32]. Additionally, the interven-
tion is informed by data demonstrating the feasibility
of reaching Spanish-speaking Latinos in Texas via a
telephone-based intervention [30], and work demonstrat-
ing the efficacy of telephone-based interventions for diet
and physical activity [33,34].
The specific aims of the study are to: 1) test the efficacy
of Motivation and Problem Solving (MAPS) to promote
and facilitate cancer risk reduction among high-risk
Mexican-origin individuals (overweight/obese smokers).
Relative to a Health Education (HE) condition, MAPS is
hypothesized to result in positive changes in each of the
primary smoking, diet, and physical activity outcomes,
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ment mechanisms (e.g., motivation, agency/self-efficacy,
stress/affect) and their potential as treatment mediators.
Motivation and problem solving (MAPS)
MAPS is a holistic, dynamic framework for behavior
change that integrates treatment elements from both
motivational interviewing (MI) [35,36] and social cogni-
tive theory [37,38]. The overarching theoretical rationale
for MAPS is the social cognitive model of behavior
change [38,39]. Social cognitive theory posits that “High
levels of both motivation and self-efficacy are important
ingredients . . . an individual may fail to engage in a spe-
cific behavior despite high levels of self-efficacy if the
motivation for performance is low or absent” [38]. That
is, theory posits that effective behavior change treat-
ments require both enhancing the motivation to achieve
and maintain change, as well as developing the self-
efficacy and skills necessary to do so. Similarly, Miller
et al. [40] note that “the key element for lasting change
is a motivational shift that instigates a decision and com-
mitment to change. In the absence of such a shift,
skill training is premature." Nevertheless, current inter-
ventions often focus largely on either motivation (e.g.,
MI-based approaches) or problem-solving/skills training
(e.g., social cognitive approaches) despite the strong the-
oretical and empirical bases for focusing on both. When
motivation is addressed, the focus is typically on motiv-
ating individuals to initiate behavior change, with little
to no focus on the motivation to maintain change or re-
cover from a relapse [22].
MAPS embeds empirically validated social cognitive
approaches within an overarching motivational enhance-
ment framework based on MI. MI is a directive but client-
centered therapeutic approach designed to minimize
resistance, enhance motivation for change, and increase self-
efficacy in a non-confrontational manner [35,36]. Several
meta-analyses have supported the efficacy of MI-based inter-
ventions for smoking, dietary behavior change, and physical
activity [41-44]. MI has been found to be effective for pro-
moting dietary change and physical activity, and our own re-
search has demonstrated the efficacy of a motivational
approach (MAPS) for smoking cessation [31,32] including
among Spanish speaking Latino smokers [30]. Similarly,
the social cognitive model has generated a tremendous
amount of intervention research demonstrating that so-
cial cognitive treatments for smoking cessation, diet,
and physical activity are effective [45,46]. However, the
relative neglect of motivation reduces their ability to ef-
fect behavior change among individuals who are not
motivated to change.
Further, although stage-based conceptualizations of
behavior change emphasize both motivation and skills
training, motivational shifts are conceptualized asrelatively stable changes in “stage” [47]. In contrast,
MAPS is relatively unique in that it conceptualizes mo-
tivation as a fluid construct that can fluctuate on a
moment-to-moment basis depending on context. Coun-
selors carefully assess and attend to changes in motiv-
ation so that treatment strategies are appropriately
matched to motivation in the moment. MAPS utilizes a
chronic care model (e.g., extended duration of treat-
ment) and is built around a “wellness program” that in
addition to focusing on cancer risk behaviors, also ad-
dresses life events, stressors, and other concerns (e.g.,
depression, family, financial, etc.). By addressing the lar-
ger context in which health behaviors occur, not only
are many of the barriers for successful behavior change
addressed, but adherence is increased because individ-
uals perceive that the counselors care about them as
whole people, and are not solely interested in their
health behaviors.Major hypothesized mechanisms
Both research and theory identify motivation, agency,
and stress/negative affect as critical mechanisms under-
lying behavior change [48-51]. As such, MAPS specific-
ally targets these mechanisms and they are hypothesized
to underlie MAPS effects on behavior change.Motivation
A large body of evidence supports the role of motivation
in the decision to change, the likelihood of change, and
the maintenance of change. Motivation, measured in
varying ways, predicts smoking quit attempts, smoking
cessation success, dietary change, and change in physical
activity [47,52-55]. There is also evidence demonstrating
that motivation can change rapidly [56-58], consistent
with models positing that motivation is dynamic and
characterized by frequent fluctuations [58]. Motivation
for the maintenance of change has received little atten-
tion despite the fact that social cognitive theory posits
that “The final and most important stage of the change
process is the maintenance stage. It is during the main-
tenance stage (which begins the moment after the initi-
ation of abstinence or control) that the individual must
work the hardest to maintain the commitment to change
over time,” [38]. More specifically, the motivation for
maintaining change may weaken and ambivalence may
increase as the individual is exposed to temptations and
stressors [38]. Therefore, MAPS includes a specific
emphasis on motivation throughout the entire change
process and on appropriate therapeutic responses to
rapid fluctuations in motivation. In MAPS, the counselor
continually attends to motivational cues and adjusts
therapeutic strategies in response to even momentary
changes in motivation.
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Human agency reflects the ability to intentionally affect
one’s behavior or life situation. Agency is determined
both by personal resources and by the contextual influ-
ences impinging on that individual [59]. Concepts
encompassed under agency include sense of control and
self-efficacy. Sense of control is a learned expectation
that outcomes depend on personal choices and actions
rather than on chance, other people, or forces outside
one’s control [50,60]. Self-efficacy is a form of agency
that is context and behavior dependent; i.e., self-efficacy
varies based on the behavior to be performed and situ-
ational demands [50,51]. A greater sense of agency is
reflected in greater self-efficacy when faced with situa-
tions that challenge one’s ability to initiate or maintain
change. Self-efficacy is a consistent predictor of behavior
change in smoking, physical activity, and fruit/vegetable
consumption [61-66]. Therefore, based on both data and
social cognitive theory [38] MAPS targets agency via the
removal of barriers to change, standard problem-solving
and coping skills training, and by increasing motivation
[38,67,68].
Stress/negative affect
Stress and negative affect, measured in many different
ways, are associated with behavior change [69-71]. In
addition, the magnitude and trajectory of stress/negative
affect over time are powerful predictors of change
[69,70], as are individual differences in affective vulner-
ability (95–98). Thus, MAPS includes stress manage-
ment and negative affect reduction strategies.
MAPS adaptation
MAPS has demonstrated efficacy for smoking cessation
among Spanish-speaking Latinos [30], to promote smok-
ing quit attempts among women [31], and preventing
postpartum relapse [32]. Thus, the MAPS program must
be adapted to additionally address fruit/vegetable con-
sumption and physical activity. Consideration of the
needs and preferences of the Mexican-origin population
in regards to fruit/vegetable consumption and physical
activity must also be addressed during adaptation. Lit-
erature review, expert consultation, and focus groups
with the target population will guide the adaptation.
Literature review
A review of the published literature will be conducted
with the goal of identifying shared barriers and facilita-
tors of behavior in regards to fruit/vegetable consump-
tion, physical activity, and smoking cessation. The
purpose of this is to identify potential targets of inter-
vention common to all three cancer risk behaviors that
can be addressed through the MAPS intervention. Lit-
erature reviews will also be conducted with the goal ofidentifying practical models of cultural self-awareness
and cross-cultural communication skills to encourage
culturally sensitive counselor-participant interactions.
Expert consultation
Two researchers (authors EGE and KR) who are experts
in motivational interventions for diet and physical activity
are being consulted for the current study. The purpose
of this is to gain expert feedback on the incorporation
of these target behaviors into the MAPS intervention,
which heretofore has been tested only with regard to
smoking [30-32].
Focus groups
Focus groups will be conducted to gain insights from
the members of the target population on exercise and
dietary habits, barriers, personal values, and the accept-
ability of program materials. Five focus groups will be
conducted. Focus group participants must meet the
same eligibility criteria as the randomized trial. A focus
group guide is being developed with input from a subset
of the study’s community advisory group that included
questions about various elements of the interventions
and materials. All recommendations for modifications to
the interventions and materials will be considered.
Pilot testing
Following MAPS adaptation, the intervention and study
procedures will be pilot tested on up to 20 individuals.
Pilot testing will replicate the study procedures through
approximately 2–3 months post-baseline assessment.
For evaluating the treatments, pilot procedures utilize
the “technology model” developed by the Yale Psycho-
therapy Development Center [72]. Briefly, after develop-
ing a good working treatment protocol, the treatment is
administered over a shortened timeframe to a small
group of participants (typically about 5–7). The coun-
selors and participants are extensively queried during
this time as to the appropriateness, acceptability, useful-
ness, etc. of all materials, assessments, procedures, and
counseling. Problems with the protocol usually become
apparent fairly quickly and the protocol is then modified
based on the feedback and a second round of pilot par-
ticipants will be enrolled. After 2–3 cycles of pilot test-
ing, the protocols are typically ready to be finalized. At
that time, participants will be formally enrolled in the
clinical trial. Pilot study participants will be compen-
sated for assessments at a rate commensurate with the
formal study participants.
Methods/design
Location and setting
The study site will be the Behavioral Research and Treat-
ment Center of The University of Texas MD Anderson
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ments, and HE sessions will occur at this location. Add-
itionally, individuals in the MAPS condition will receive
telephone counseling based out of the Department of
Health Disparities Research at The University of Texas
MD Anderson Cancer Center.
Ethics and trial registration
The current study was funded by National Cancer Insti-
tute (NCI) Grant U54CA153505. The study was approved
by the Institutional Review Board of The University of
Texas MD Anderson Cancer Center (Protocol #: 2010–
0606), and is registered on the National Institutes of
Health Clinical Trials Registry (available at ClinicalTrials.
gov. Registration #: NCT01504919).
Study population and eligibility
The study population will be overweight or obese
Spanish-speaking Mexican- or Mexican-origin smokers
who reside in the Houston, Texas, metropolitan area. In-
clusion criteria will be: 1) self-report of Mexican heritage;
2) age 18 or older; 3) current smoker with a history of
smoking an average of at least one cigarette per day dur-
ing the last year; 4) register an expired carbon monoxide
level of at least five parts per million; 5) body mass index
≥ 25 based on measured height and weight; 6) ability to
engage in low to moderate physical activity as determined
by the Physical Activity Readiness Questionnaire PAR-Q;
[73]; 7) blood pressure reading <140/90 millimeters
of mercury (mm Hg); 8) speak Spanish, and; 9) have a
valid home address and a functioning telephone number.
Participants do not need to be motivated to change
their behavior.
Participants with high blood pressure readings defined
as ≥ 140/90 mm Hg; [74] and those deemed ineligible
based on the PAR-Q will be able to participate if they
provide a letter from a physician who will continue
to monitor the participant during the research study. Ex-
clusion criteria include: 1) women who are pregnant or
currently lactating; 2) contraindication for nicotine
patch; 3) other active substance abuse or dependence; 4)
regular use of other tobacco products; 5) current use of
tobacco cessation medications; 6) currently enrolled in
another study; 6) another household member enrolled in
the study, and; 6) a score below 38 on the Short Assess-
ment of Health Literacy for Spanish Adults SAHLSA;
[75]. Ineligible individuals will be given referrals to com-
munity resources.
Recruitment and consent
Participants (N = 400) will be recruited from the ongoing
Mexican American Cohort Study (n > 20,000) in the
Houston area and from the community. The Mexican
American Cohort study was created in 2001 to assessgenetic and non-genetic risk factors for cancer in this
population. Recruitment procedures have been described
in detail elsewhere [76]. Briefly, participants have been
recruited through multiple strategies, including random
digit dialing, block walking in predominantly Mexican
American neighborhoods (i.e., >75% based on 2000 U.S.
Census), from community centers and health clinics,
and networking through currently enrolled participants.
Participants are contacted every 6 months to obtain
updated health status and contact information.
For this study, overweight/obese smokers will be identi-
fied from the cohort study database as potential partici-
pants and will be contacted by research staff. Participants
will additionally be recruited via radio and print advertise-
ments and direct community outreach. Potential partici-
pants recruited via advertisements will be instructed to
call the study telephone line and provide contact informa-
tion to learn more about the study. All potential partici-
pants will be contacted via telephone by research staff to
assess their interest in participating. Potential participants
will receive a description of the study and will be asked if
they are interested in participating. Those who are inter-
ested will complete screening over the phone (upon giving
verbal consent to be screened), and a baseline visit will
be scheduled within two weeks. At the baseline visit, a
research coordinator will provide another detailed de-
scription of the study, answer questions, and obtain
written informed consent to participate in the study.
The entire consent process will be completed in Spanish
by bilingual research staff, and consent documents will be
written in Spanish.
Study design
The current study is a two-group randomized controlled
trial designed to test the efficacy of MAPS versus HE for
multiple cancer risk behaviors among Spanish-speaking
Mexican-origin smokers. Figure 1 depicts the study flow.
Potential participants will call a phone number dedicated
to study recruitment. They will undergo an initial eligi-
bility screening (including BMI and smoking status eligi-
bility based on self-report). Those who pass the initial
screening and choose to participate will be scheduled to
attend an in-person visit at the study site. Additional
screening will take place, including objective verification
of height, weight, and smoking status. Participants will
also be screened for health literacy. After completing
additional screening, those who choose to participate
will complete the baseline assessment and the first of
three HE sessions. After completing the first HE session,
participants will be randomly assigned to HE or MAPS.
Randomization will occur using a form of adaptive
randomization called minimization [77,78]. Compared to
techniques such as stratification, minimization results
in better group balance on participant characteristics.
Recruitment and 
Telephone 
Screen
In-person screen, 
enrollment (if eligible), 
baseline assessment, 
first Health Education 
session, and 
randomization 
Up to18 MAPS 
Counseling 
Calls over 18 
months
Health 
Education
6-month follow-up 
assessment and 
second Health 
Education session
12-month follow-up 
assessment and third 
Health Education 
session 
18-month follow-up 
assessment
Figure 1 Study flow.
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throughout the randomization process. Randomization
will be balanced on gender, age, immigrant status, ciga-
rettes per day, and BMI.
Individuals randomized to the MAPS condition will
schedule their first counseling call during the baseline
visit, and subsequently receive up to 18 counseling calls
over an 18-month period. Outcome assessments will
occur at baseline, 6 months, 12 months, and 18 months.
Also after completing the assessment and randomization
procedures, the 6-month follow-up visit will be sched-
uled for all participants. Research staff conducting theoutcome assessments will be blinded to participants’
treatment conditions.
Control and treatment conditions
HE condition
HE will include three sessions of brief advice (10 -
minutes) regarding smoking cessation, diet, and physical
activity change, including the provision of referrals to re-
sources for behavior change (e.g., Texas Quitline, com-
munity diet and physical activity programs). Participants
will also receive Spanish language self-help materials.
Participants will be given a home-based exercise kit (e.g.,
pedometer, exercise ball, strength training cables) and
related instruction on the use of the exercise kit’s con-
tent during the first HE session. When the participant
informs research staff that s/he is ready to make a smok-
ing cessation attempt, a 6-week supply of free nicotine
patches will be provided. HE will occur a total of 3 times
(during the in-person assessment appointments at base-
line, 6 months, and 12 months).
MAPS condition
The treatment condition will include HE plus up to 18
proactive, telephone-delivered MAPS counseling ses-
sions over the 18-month period. Each counseling call
will last approximately 20–30 minutes. Call frequency is
negotiated between participant and counselor based on a
participant’s motivation and needs. For example, several
calls might be clustered around the initiation of a walk-
ing program, a smoking cessation attempt, holiday diet
challenges, or specific barriers that the participant is
facing (e.g., stress, lack of social support, family prob-
lems, financial crisis). Conversely, calls might be sched-
uled very infrequently when the participant is doing
well. Regardless of when calls have been scheduled, par-
ticipants are always able to call the study telephone line
and request a counseling call.
All participants will complete a Wellness Plan in col-
laboration with their MAPS counselor. The Wellness
Plan is an organization of goals or areas of concern/im-
portance that the participant wants to work on during
counseling. Wellness Plan items may include change
goals for participants who are ready to make changes.
The Wellness Plan may also include areas of concern or
other topics that the participant would like to discuss
where they may or may not be ready to change. Thus,
the Wellness Plan will also be used in work with partici-
pants who are not motivated to make changes. This is
because, although MI will be the primary task being
used in working with these participants, it may be help-
ful to list areas of concern or topics that the participant
is simply willing to explore and revisit. Wellness Plan
goals can include not only goals related to the target
behaviors, but also a plan for addressing other salient
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problems, etc. The Wellness Plan can also include plans
for connecting participants with resources in the com-
munity to address their needs, such as vocational and
educational training, and free or low cost childcare and
medical treatment. The Wellness Plan is a central
organizational component of counseling. Thus, although
a participant can develop a Wellness Plan as early as the
first few sessions, it is revisited and revised over time to
reflect participants’ progression through the program or
any new areas of emphasis.
MAPS is designed to tailor counseling sessions com-
pletely around the participant’s expressed readiness to
change a target behavior, and their unique needs and pref-
erences for coping skills. Thus, it is unlikely any two par-
ticipants will progress through the program at the same
pace or express/address identical concerns. However, the
general progression is broadly organized as follows: Early
MAPS counseling sessions (e.g., 1–5) are intended for
introduction to the target behaviors and an assessment of
the participant’s motivation to change any or all of smok-
ing, fruit/vegetable consumption, and physical activity.
Where the participant expresses readiness, Problem Solv-
ing/Skills Training techniques are utilized to facilitate
change. Where the participant is not yet ready, a MI ap-
proach is utilized. Later sessions (e.g., 7–16) are used ei-
ther for continued MI in the areas where the client
expresses not being ready to change, action oriented coun-
seling to facilitate change, or maintenance of change, Ses-
sions 17 and 18 prepare the participant for ending the
program and include a final review of goals and progress,
saying good-bye, and providing any additional necessary
referrals.
Counselor qualifications, calls, and training
MAPS has been developed to be appropriate for delivery
by lay and professional health workers. Counselors re-
ceive approximately 40 hours of MAPS training initially
with “booster” sessions of approximately 1–2 hours every
1–2 months during the study. Training continues until the
counselor reaches competence and adherence criteria.
Miscellaneous counseling issues are also discussed at
weekly project meetings. This level of training and on-
going monitoring is consistent with the recommended
level of training for real-world providers of health promo-
tion interventions such as Quitline counselors [79] and
ensures that MAPS is of the highest quality and follows
the protocol precisely, both of which are key fidelity issues
in evaluating new treatments. Counselors will be two
Spanish-speaking members of the study staff who are ex-
perienced in the delivery of MAPS.
Treatment fidelity To monitor drift, all calls are digitally
recorded and encrypted. A random sample of 10% of callsare coded using a modified Motivational Interviewing
Treatment Integrity Manual MITI; [80]. The MITI has
empirically validated reliability and validity, and is modi-
fied to include coding around appropriate social cognitive/
problem-solving strategies, and transitions between the
motivation building and problem-solving. Because MAPS
utilizes a MI framework, the MITI works well for ensuring
adherence to the protocol and utilizing the general MI
spirit. A counselor who falls below performance criteria
will receive additional training.
Instruments
The majority of the assessment instruments have been pre-
viously used and validated in Spanish, or are being tested in
our current research. Assessment instruments measure
outcomes or hypothesized mechanisms. We attempted to
reduce the inconvenience associated with completing the
assessment battery by providing financial compensation for
participants’ time and by using the Questionnaire Design
System (QDS), a computer-administered self-interview for-
mat. The error and time necessary to complete an assess-
ment battery are substantially reduced by using QDS and
particularly so among individuals with low literacy because
the computer can read each item in Spanish to the partici-
pants. Assessment procedures will be identical at each of
the four visits, with the exception that only a subset of the
demographic measures will be administered at the 6, 12,
and 18 month follow ups.
Primary outcomes
Physical activity
International physical activity questionnaire (IPAQ)
The IPAQ assesses walking for exercise, walking for
transportation, moderate and vigorous physical activity,
and time spent sitting. It is widely used to measure phys-
ical activity [73].
Accelerometer Participants will wear a small blinded
accelerometer (i.e., participant cannot see values) over 7 -
days to assess physical activity. Accelerometers will be
distributed at each assessment visit and will be returned
via mail.
Fruit/vegetable consumption
National health interview survey diet items Items will
be used to assess frequency of food intake in 16 broad
categories to estimate intakes of fruits and vegetables,
percentage energy from fat, and fiber diets [81].
Two-item food frequency questionnaire The two-item
food-frequency questionnaire was developed to estimate
intake of fruit and vegetables [82].
Castro et al. BMC Public Health 2013, 13:237 Page 8 of 15
http://www.biomedcentral.com/1471-2458/13/237Smoking abstinence
Assessments will follow the recommendations from the So-
ciety for Research on Nicotine and Tobacco for cessation
induction trials [83]. Participants will provide breath carbon
monoxide to verify smoking. Although carbon monoxide
has a relatively short half-life, the most comprehensive re-
view on biochemical validation concluded that misreporting
is typically very low (~2%) except for populations with sub-
stantial incentives to misreport (i.e., adolescents, pregnant
women), and that adjustment for misreporting almost
never influences analyses regarding relative treatment effi-
cacy [84]. Participants will also provide a saliva sample to
verify smoking status. The saliva sample will be provided at
the baseline, 6 month, 12 month and 18 month follow-up
visits. Saliva samples will be analyzed for cotinine, a meta-
bolic byproduct of nicotine that provides an estimate of
nicotine consumption. A saliva cotinine level of <20 ng/ml
will be considered as abstinent.
Smoking status questionnaire
This surveys tobacco use, use of other tobacco products,
and nicotine replacement medications. The questionnaire
also collects data on the use of other tobacco products
and nicotine replacement medications as determined by
the participant's time point in the protocol (e.g., based
upon the date the participant quits smoking) [83].
Measures of hypothesized treatment mechanisms
Barriers self-efficacy physical activity
The Barriers Self-Efficacy Physical Activity is a 5-item
measure on a five-point Likert-type and measures one’s
confidence to meet a physical activity goal in the face of
barriers to the behavior [85].
Fruits and vegetables self-efficacy
The Fruits and Vegetables Self-efficacy is a 7-item meas-
ure on a 5-Likert scales. Items assess family influences,
decisional balances, and fruit and vegetable intake [85].
Fruits and vegetables staging
This is a 2-item measure of daily intake of fruits and
vegetables and intent to change the current intake of
fruit and vegetables.
Motivation
Motivation to abstain from smoking will be assessed
with a 10-item scale currently being developed by our
research team in order to assess motivation as a con-
tinuous variable as opposed to a stage. Items assess the
motivation to quit smoking [86].
Positive and negative affect scale (PANAS)
The PANAS is comprised of two mood scales with high re-
liability, Positive Affect (PA) and Negative Affect (NA) [87].Self-efficacy scale
This is a 9-item scale reflecting the confidence of the in-
dividual that they can cope with high-risk situations
without smoking [88].
Smoking self-efficacy/confidence
The Smoking Self-Efficacy/Confidence scale assesses an
individual's confidence to abstain from substance use or
health behaviors in a variety of different situations. It
consists of 9-item with 5 responses ranging from not at
all confident to completely confident [88].
Smoking status questionnaire
This surveys tobacco use, use of other tobacco products,
and nicotine replacement medications. The questionnaire
also collects data on the use of other tobacco products
and nicotine replacement medications as determined by
the participant's time point in the protocol (e.g., based
upon the date the participant quits smoking) [83].
Stages of change: physical activity
The Stages of Change: Physical Activity is a 1-item meas-
ure of the five stages of change in physical activity [89].
Other measures
Brief Wisconsin Inventory of Dependence Motives
This questionnaire yields an overall dependence score as
well as subscale scores for other critical dimensions of to-
bacco dependence (affiliative attachment, automaticity, loss
of control, cognitive enhancement, craving, cue exposure/
associative processes, social/environmental goads, taste, tol-
erance, weight control, and affective enhancement). The
overall and subscale scores have high internal consistencies
and predict abstinence [90].
Demographics Questionnaire collects data on age, race,
ethnicity, education, income, preferred language, and
generations in the U.S.
Medical history
Participants will be asked to provide a detail medical his-
tory including heart disease, asthma/lung disease, high
blood pressure, diabetes, high cholesterol, thyroid prob-
lems, and kidney disease.
Medication worksheet
Participants will be asked to provide a detail list of medi-
cations and their dosage that they take daily.
Short assessment of health literacy for Spanish adults
(SAHLSA)
The SAHLSA will be used to assess Spanish language
health literacy. Participants are presented with a list of
50 common medical terms. Each word is presented with
a synonym and a distracter word. The participant is
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synonym. A score of 38 is indicative of at least marginal
health literacy, and higher scores indicate greater health
literacy [75].
Pharmacotherapy
All study participants will have access to free nicotine
patch therapy when they are ready to make a quit attempt.
The provision of patch therapy or other cessation medica-
tion is the recommended standard of care. As such, it is
arguably an ethical obligation to provide all participants
with access to patch therapy. Study participants receive
nicotine patch therapy because the patch is currently rec-
ognized as a frontline therapy [22], and compared to non-
nicotine medications such as bupropion or varenicline,
the patch is safer, better tolerated, and available over the
counter. Participants who decide to make a quit attempt
will request patches by contacting project staff. Patches
and instructions for their use will be distributed either via
a visit to MD Anderson or via the mail. Patch therapy for
participants who smoke >10 cigarettes/day will consist of
4 weeks of 21 mg patches, 1 week of 14 mg patches, and
1 week of 7 mg patches. Patch therapy for participants
who smoke 6–10 cigarettes/day will consist of 4 weeks of
14 mg patches and 2 weeks of 7 mg patches. Patch therapy
for participants who smoke 1–5 cigarettes/day will consist
of 6 weeks of 7 mg patches. A reduction in dosage or
cessation of the patch regimen will be implemented for
any participants who report signs of being on too high
of a dose, although this is typically not necessary for par-
ticipants because blood nicotine levels are usually far
lower on the patch than while smoking [91]. In sum, all
participants, regardless of treatment group assignment,
will have the same access to nicotine patch therapy.
We will carefully track pharmacotherapy use at all follow-
up assessments.
Participant compensation and retention
To compensate for the time and inconvenience associ-
ated with participation, participants will be reimbursed
$25 for each of the 4 assessments (i.e., up to a total of
$100). Focus group participants will receive a gift card
worth $50. Pilot study participants will receive a $25 gift
card at each visit (Day 1 and Month 3), for a total of up
to $50 in gift cards. Participants will not receive com-
pensation for the counseling calls. Other procedures to
reduce attrition include: 1) mailing postcard reminders
and calling to remind participants of upcoming visits; 2)
maintaining communication with participants through-
out the study via birthday cards, holiday cards, etc. (each
mailing includes a stamped address update postcard to
update contact information); 3) having research staff
member available during daytimes, evenings, and week-
ends to conduct study visits; 4) requiring that in additionto a functional phone number (necessary for counseling
calls), participants have a home address so that they can
be contacted by mail if necessary; and 5) obtaining
names, addresses, and phone numbers of up to three
collaterals (i.e., relatives/friends) who can provide infor-
mation on participants’ whereabouts during the study
(permission to contact the collaterals will be obtained
from participants).Data analysis
Primary outcomes used to evaluate the efficacy of the
MAPS intervention (Aim 1) are smoking status, servings
of fruits and vegetables, and both self-reported and object-
ively measured physical activity assessed at the 6, 12, and
18 months. Because the primary outcomes and mecha-
nisms include repeated measurements that are correlated
within subjects, the data analytic approach utilizes gener-
alized linear mixed model regression GLMM; [92,93].
Model diagnostics will be used to determine and address
the form of the covariances, transformations, collinearity,
and influential observations. GLMM parameter tests will
be conducted using Wald statistics, and will be adjusted
for multiple comparisons where appropriate. Adjustments
for multiple comparisons will be made according to the
method of Westfall and Young [94]. In this approach, the
correlations among the dependent variables are used to
adjust the critical values of the individual tests to ensure
that the probability of a Type I error across a set of tests
does not exceed the chosen alpha level. This approach has
the advantage of maintaining the chosen Type I error
rates while at the same time providing a less conservative
adjustment than Bonferonni-type procedures.Aim 1
Evaluate the efficacy of a MAPS approach to promoting
and facilitating reduction of behavioral risk factors for
cancer among high-risk Mexican-origin individuals (over-
weight/obese smokers). Relative to HE, MAPS is hypothe-
sized to result in positive changes in each of the primary
smoking, diet, and physical activity outcomes.
GLMM will be utilized in analyzing the effects of
MAPS on the primary outcomes across the 6, 12, and
18-month time points. For the dichotomous outcome,
we will assume a logit link and binomial variance func-
tion for the GLMM, and parameterize them with
blocking on individual nested within treatment condi-
tion. Treatment and time will be included, as well as
their interaction, with adjustment for relevant covariates
as necessary. Time will be treated as a categorical vari-
able. These models test for the main effects of treatment
and time, and whether the treatment effect varies over
time. For the continuous outcomes, the GLMM analysis
will be replaced by linear mixed model (LMM) analysis
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variable is continuous).
Aim 2
Assess the effects of MAPS on hypothesized treatment
mechanisms (e.g., motivation, agency/self-efficacy, stress/
affect) and the role of those mechanisms in mediating the
effect of MAPS on outcomes.
To assess MAPS effects on treatment mechanisms, ana-
lyses largely analogous to the GLMM and LMM analyses
described for Aim 1 will be conducted. Mediation will be
indicated if: (a) there is a significant MAPS effect on the
mechanism, and (b) the mechanism significantly predicts
the outcome when adjusting for treatment. To formally
test for the mediation effect, we will follow appropriate
methods described by MacKinnon [95]. In particular, we
will use a product-of-coefficients approach in which the
indirect (mediation) effect is defined as the product of the
coefficient of the intervention condition in the regression
of the mechanism (a path) and the coefficient of the
mechanism in the regression of the outcome variable
controlling for intervention condition (b path), with ap-
propriate coefficient standardization from b path, when
the outcome is binary [95]. This approach is applicable
for both continuous and binary outcomes (e.g., smoking
status, servings of fruits and vegetables, and both self-
reported and objectively measured physical activity),
with and without repeated measurements. We will use a
bootstrapping approach to computing confidence inter-
vals of the indirect effects. Multiple mediator models
will be fit to assess simultaneous mediation effects by
multiple mechanisms. In addition to the tests for indirect
effects, we will also calculate proportion mediated effects
and standard errors in both the simple and multiple
mediator models.
Missing data and drop-outs Some individuals will fail
to complete all assessments. GLMM is designed to han-
dle missing data and will give valid inferences for effects
provided that the probability of missing data depends
only on the observed outcome and/or covariates in the
model (or data are missing at random or missing com-
pletely at random). We will conduct analyses to examine
whether participants who drop out of the study differ
from those who do not, and control for those character-
istics that are unbalanced between dropouts and com-
pleters and believed to be associated with the outcomes.
In case where non-ignorable dropout [96] is suspected,
our primary analysis approach will use a conservative
one of coding the missing outcome as a failure. For ex-
ample, a missing smoking outcome could be coded as
smoking. In addition, we will conduct sensitivity ana-
lysis using selection models to account for non-
ignorable dropouts. Specifically, we will follow theapproach of Diggle and Kenward [97] to model the
dropout as a function of both the currently unobserved
and previously observed values of the outcome variables
(e.g., when dropout is due to lack of improvement in
the outcome). Alternatively, we can consider a slope-
dependent dropout mechanism [98,99] to account for
non-ignorable missingness. In this model, participants
are believed to drop out with a high probability if the
underlying (unobserved) rate of their change of out-
come (e.g., physical activity level) over time is low. In
spite of the availability of these potentially useful
missing-data handling techniques, we do not expect
they will lead to remarkably different results or conclu-
sions given our consistently high follow-up rates
[30,100-103].
Power
All power analyses assume a significance level of 0.05
and a two-sided test and accounts for a potential 20%
attrition at all time points (N = 320; 160/group). Three
of the outcomes are continuous (servings of fruits and
vegetables, METS of physical activity, accelerometer
assessed activity). One outcome (smoking status) is
dichotomous. Power is expected to be greater for
intent-to-treat analyses than the power reported here,
which represents completers only analyses. This is because
the total number of cases for intent-to-treat analyses will
be 400, versus 320 for the completers only analyses. For
intent-to-treat analyses, those lost to follow up will be
coded as not abstinent.
Continuous outcomes
Because treatment outcomes are measured at 6, 12, and
18 months, treatment effects may not be consistent
across time points. In the case of a constant treatment
effect across time, the detectable difference depends on
the intraclass correlation coefficient (ICC) between mea-
surements taken from a given participant. Since 160 par-
ticipants per arm are assumed after attrition, and there
are 3 measurements per participant, the effective sample
size (ESS) per arm is 3*160/VIF, where VIF is the vari-
ance inflation factor 1 + (p-1)*ICC. In this formula, p is
the average number of observations per participant.
Table 1 shows the minimal detectable constant treat-
ment effect under a range of values for the ICC when
testing at a power of 80%. The detectable differences are
given in terms of the standard deviation of the error
term of the model. Thus, if the ICC is 0.3, the current
study has 80% power to detect a shift of 0.229 standard
deviations between the treatment arms, a small effect
size per Cohen [104]. Power calculations displayed in
Table 1 assume approximately consistent effects of treat-
ment across measurements. However, correlations be-
tween more distal time points are generally lower than
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in Table 1 represent a worst-case scenario. We further
computed power for detecting an average intervention
difference of 0.3 when the effect varies across time
points, specifically, with a shift of 0.1 at 6 months, 0.3 at
12 months, and 0.5 at 18 months. A Geisser-Greenhouse
Corrected F Test was used for testing the intervention
effect. The estimated power for detecting the treatment
effect was 99%, 96%, and 91% for ICC values of 0.1, 0.3,
and 0.5, respectively. It is important to note that the
presented case of a 0.1, 0.3, and 0.5 increasing difference
across time points produces exactly the same power as
that of a 0.5, 0.3, and 0.1 decreasing difference across
those time points.Binary outcomes
National data suggest that approximately 5% of the gen-
eral population of smokers quit each year [105]. How-
ever, smokers in HE receive a brief treatment based on
national recommendations [22]. Therefore, we estimate
that the abstinence rate for HE will be approximately
5%, 10%, and 15% across the three follow-ups (i.e., 10%
quit rate per year). Power calculations for correlated bin-
ary outcomes are more complex than continuous out-
comes, which require simulations. For example, it is not
possible to have the same ICC between all pairwise ob-
servations. Therefore, the mean of all pairwise ICC
values was used as the overall ICC and looked at three
potential scenarios based on the simulation of 1000 tri-
als. Using the estimated quit rate for HE of 5%, 10%,
and 15% across the three follow-ups, Table 2 shows
simulation results for constant, increasing, and decreas-
ing differences between arms for each time point at ICC
values of 0.1, 0.3, and 0.5. For cessation induction trials
such as this one, the most likely scenario would be in-
creasing differences over time given that 80-90% of
smokers will not be motivated to quit at Baseline. Re-
gardless, power is very good for detecting reasonable
and meaningful differences between groups under realistic
scenarios.Table 1 Minimal detectable difference with constant
effect
ICC VIF ESS Detectable difference
0.0 1.0 480 0.181
0.1 1.2 400 0.198
0.3 1.6 300 0.229
0.5 2.0 240 0.256
1.0 3.0 160 0.314
Note: ICC = intraclass correlation coefficient; VIF = Variance Inflation Factor; ESS =
Estimated Sample Size.Discussion
Interventions addressing multiple cancer risk factors have
shown great promise, [25-27], and a variety of approaches
and settings have been utilized to address multiple cancer
risk factors. For example, both worksite and health center
based multiple risk factor interventions have shown effi-
cacy with respect to improving diet and physical activity,
but smoking cessation results have generally not been
as positive [25,26,106-109]. Overall, multiple risk factor
interventions provide an exceptionally promising and
efficient means by which to facilitate behavior change
and reduce cancer risk. Further, telephone-based inter-
ventions have demonstrated efficacy and broad reach as
a method of of delivering smoking cessation, physical
activity and diet/nutrition interventions [30-34]. The
proposed study builds on this work using an interven-
tion approach that has already been proven effective
addressing smoking [30]. This intervention will be
adapted, through literature review, expert consultation,
and qualitative work, to simultaneously address smoking
cessation, fruit/vegetable consumption, and physical
activity, and to be sensitive to the needs of the target
population. To the best of our knowledge, the current
study will be among the first multiple risk factor
intervention studies to focus on Mexican-origin indi-
viduals in general, and more specifically on overweight/
obese Mexican-origin smokers, an extremely high risk
group.
MAPS combines two widely utilized and empirically
validated approaches [36,39] into a comprehensive, pro-
active, holistic approach that is specifically tailored to
the motivational state, life concerns, and needs/prefer-
ences of the target population. MAPS is built around an
individualized “wellness program” that is based on both
successful chronic care models, patient navigation pro-
grams, and feedback from underserved communities. In
addition to providing the necessary long-term support
and strategies to initiate and maintain change, such an
approach could potentially be more cost-effective than
shorter interventions because of its effects on increasing
the durability of treatment effects. Despite enthusiasm
for more chronic care type approaches to behavior
change, there have been few attempts to actually develop
such programs. Moreover, telephone-based multiple risk
factor counseling can both reduce the total number of
risk factors, and be most effective among individuals
with the greatest risk i.e., among individuals with larger
numbers of risk factors; [26]. Further, treating cancer
risk factors within a chronic care model, as MAPS does,
has the potential to boost long-term success rates by
improving the ability of an intervention to promote
motivation, aid change attempts, prevent relapse, and
encourage recycling among individuals who are unsuc-
cessful [110-113].
Table 2 Simulation results
Constant differences Increasing differences Decreasing differences
6 months 12 months 18 months 6 months 12 months 18 months 6 months 12 months 18 months
HE 0.05 0.10 0.15 HE 0.05 0.10 0.15 HE 0.05 0.10 0.15
MAPS 0.15 0.20 0.25 MAPS 0.10 0.20 0.30 MAPS 0.20 0.20 0.20
difference 0.10 0.10 0.10 difference 0.05 0.10 0.15 difference 0.15 0.10 0.05
ICC power 95% CI ICC power 95% CI ICC power 95% CI
0.10 0.99 0.98-1.00 0.10 0.99 0.98 1.00 0.10 0.99 0.98-1.00
0.30 0.94 0.93-0.95 0.30 0.95 0.94 0.96 0.30 0.98 0.97-0.99
0.50 0.79 0.76-0.82 0.50 0.84 0.82 0.86 0.50 0.98 0.97-0.99
Note: HE = Health Education; MAPS =Motivation And Problem Solving; ICC = intraclass correlation coefficient; CI = confidence interval.
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